The diaTribe Foundation hosted a day of lively discussions on standardizing and implementing outcomes #BeyondA1c in drug development, FDA approval, research, and access...

A study recently published in the New England Journal of Medicine shows that a bionic pancreas, or a closed-loop automated insulin delivery system, kept blood glucose...

In October 2022, Dexcom announced that its next-generation continuous glucose monitor (CGM), Dexcom G7, is now available to people with diabetes in Hong Kong and several...

Continuous glucose monitors (CGM) are a valuable tool, allowing people with diabetes to stay informed to make decisions without having to constantly prick their fingers...

Healthcare providers and people with diabetes are finding that time in range (TIR) provides clear and timely information for managing your blood glucose. diaTribe Senior...

Public speaking professor Alan Uphold shares his experiences with severe low blood sugars and explains why it’s so important to communicate with your loved ones and care...

Unfortunately, healthcare professionals can sometimes contribute to diabetes stigma. However, discussing Time in Range may help empower people with diabetes and reduce...

A fully virtual six-month clinical trial is recruiting 300 people with type 1 and type 2 diabetes who are interested in trying continuous glucose monitoring (CGM) with...

The Eversense E3 continuous glucose monitor (CGM) has been approved by the FDA and it has received a CE Mark approval in Europe for people with diabetes aged 18 and...

Time in range (TIR) is an actionable metric that captures the highs, lows and in-range glucose values that people with diabetes experience each day. Because TIR shows...

A team of world-renowned experts in diabetes presented updates about automated insulin delivery (AID), focusing on the role of diet and exercise for closed-loop systems.

In April 2022, 32 of the world’s premier diabetes experts gathered in Barcelona, along with representatives from industry, advocacy, and regulatory bodies, to discuss...

​For the first time, Time in Range was used as the main outcome measured in a clinical trial for a diabetes medication. Read about the study results and implications.

Find out more from experts about the latest advancements in continuous glucose monitoring, ketone monitors, and non-invasive technologies.

The diaTribe team was on-the-ground in Barcelona, Spain to cover the latest news in diabetes technology from the ATTD 2022 international conference. Here are our top...

At this year’s Advanced Technologies and Treatment conference in Barcelona, diaTribe will bring together dozens of experts in diabetes for a revolutionary consensus...

A low carb diet can be difficult to follow, especially for children. Katie Bacon explains several ways in which low carb principles can be adapted to real life

The diaTribe team is excited to cover all the latest news in diabetes technology and treatments, attending our first in-person diabetes conference in over two years!...

Time in Range (TIR) is a well established and easy to use measurement of your daily glucose management. The glycemia risk index (or dysglycemia index) is an emerging...

Time in Range (TIR) is an effective tool to use in your daily diabetes management, but how can you actually spend more of your day in range? Read below for some helpful...